{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:02:25Z","timestamp":1787238145065,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"am","delay-in-days":310,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["U01 HL143403"],"award-info":[{"award-number":["U01 HL143403"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016606","name":"Riley Children's Foundation","doi-asserted-by":"publisher","award":["P30 CA082709"],"award-info":[{"award-number":["P30 CA082709"]}],"id":[{"id":"10.13039\/100016606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013740","name":"Plastic Surgery Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013740","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA258737"],"award-info":[{"award-number":["R01 CA258737"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA232419"],"award-info":[{"award-number":["R01 CA232419"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA167291"],"award-info":[{"award-number":["R01 CA167291"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA023168"],"award-info":[{"award-number":["P30 CA023168"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA254110"],"award-info":[{"award-number":["R01 CA254110"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA264471"],"award-info":[{"award-number":["R01 CA264471"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jconrel.2025.02.075","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T19:09:07Z","timestamp":1740683347000},"page":"113579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Timely administration of drug combination improves chemoimmunotherapy of an immune-cold tumor"],"prefix":"10.1016","volume":"381","author":[{"given":"Fanfei","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyue","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Gutierrez","family":"Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa L.","family":"Fishel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy L.","family":"Ratliff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.02.075_bb0005","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/1759-7714.13867","article-title":"Anti-PD1 versus anti-PD-L1 immunotherapy in first-line therapy for advanced non-small cell lung cancer: a systematic review and meta-analysis","volume":"12","author":"Brito","year":"2021","journal-title":"Thoracic Cancer"},{"key":"10.1016\/j.jconrel.2025.02.075_bb0010","doi-asserted-by":"crossref","first-page":"18536","DOI":"10.1021\/jacs.1c08132","article-title":"Rational Design of Potent Peptide Inhibitors of the PD-1:PD-L1 interaction for Cancer immunotherapy","volume":"143","author":"Yin","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0015","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa2210233","article-title":"Tumor-infiltrating lymphocyte therapy or ipilimumab in advanced melanoma","volume":"387","author":"Rohaan","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15051414","article-title":"CAR T cell therapy in glioblastoma: overcoming challenges related to antigen expression","volume":"15","author":"Luksik","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2025.02.075_bb0025","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/CJI.0b013e3182518e83","article-title":"Cancer and innate immune system interactions: translational potentials for cancer immunotherapy","volume":"35","author":"Liu","year":"2012","journal-title":"J. Immunother."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00294647","article-title":"Monocyte subpopulations in human gliomas: expression of fc and complement receptors and correlation with tumor proliferation","volume":"80","author":"Morimura","year":"1990","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0035","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3171\/jns.1979.50.3.0305","article-title":"Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors","volume":"50","author":"Morantz","year":"1979","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nn.4185","article-title":"The role of microglia and macrophages in glioma maintenance and progression","volume":"19","author":"Hambardzumyan","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0045","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.immuni.2017.07.014","article-title":"Tissue-resident macrophages in pancreatic ductal adenocarcinoma originate from embryonic hematopoiesis and promote tumor progression","volume":"47","author":"Zhu","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.02.075_bb0050","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/hed.27722","article-title":"Characterization of the tumor microenvironment in the mouse oral cancer (MOC1) model after orthotopic implantation in the buccal mucosa","volume":"46","author":"Kansal","year":"2024","journal-title":"Head Neck"},{"key":"10.1016\/j.jconrel.2025.02.075_bb0055","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-032414-112043","article-title":"Innate immune recognition of Cancer","volume":"33","author":"Woo","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0060","doi-asserted-by":"crossref","first-page":"1039260","DOI":"10.3389\/fimmu.2022.1039260","article-title":"The role of innate immune cells in the tumor microenvironment and research progress in anti-tumor therapy","volume":"13","author":"Lu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0065","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/blood-2018-11-844548","article-title":"Neutrophil plasticity in the tumor microenvironment","volume":"133","author":"Giese","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2025.02.075_bb0070","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2122595119","article-title":"A single local delivery of paclitaxel and nucleic acids via an immunoactive polymer eliminates tumors and induces antitumor immunity","volume":"119","author":"Meng","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.02.075_bb0075","first-page":"4355","article-title":"Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase","volume":"54","author":"Long","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0080","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","article-title":"The cGAS-STING pathway as a therapeutic target in inflammatory diseases","volume":"21","author":"Decout","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0085","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3389\/fimmu.2020.00615","article-title":"Research advances in how the cGAS-STING pathway controls the cellular inflammatory response","volume":"11","author":"Wan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0090","first-page":"1452","article-title":"The cGAS\u2013STING pathway and cancer, nature","volume":"3","author":"Samson","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2025.02.075_bb0095","first-page":"1061","article-title":"Established T cell-inflamed tumors rejected after adaptive resistance was reversed by combination STING activation and PD-1 pathway blockade, Cancer","volume":"4","author":"Moore","year":"2016","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0100","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.immuni.2018.06.006","article-title":"Tumor cell-intrinsic factors underlie heterogeneity of immune cell infiltration and response to immunotherapy","volume":"49","author":"Li","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.02.075_bb0105","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/01.cji.0000436722.46675.4a","article-title":"Immunogenicity of murine solid tumor models as a defining feature of in vivo behavior and response to immunotherapy","volume":"36","author":"Lechner","year":"2013","journal-title":"J. Immunother."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0110","first-page":"149","article-title":"Combination of 4-1BB agonist and PD-1 antagonist promotes antitumor effector\/memory CD8 T cells in a poorly immunogenic tumor model, Cancer","volume":"3","author":"Chen","year":"2015","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0115","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s42003-020-0916-2","article-title":"Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models","volume":"3","author":"Waaler","year":"2020","journal-title":"Commun Biol"},{"key":"10.1016\/j.jconrel.2025.02.075_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119296","article-title":"In-vitro and in-vivo difference in gene delivery by lithocholic acid-polyethyleneimine conjugate","volume":"217","author":"Wang","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.02.075_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201703670","article-title":"A comparative in vivo study of albumin-coated paclitaxel nanocrystals and Abraxane","volume":"14","author":"Park","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2025.02.075_bb0130","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1200\/JCO.21.01293","article-title":"Weekly cisplatin plus radiation for postoperative head and neck Cancer (JCOG1008): a multicenter, noninferiority, phase II\/III randomized controlled trial","volume":"40","author":"Kiyota","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0135","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1158\/2159-8290.CD-11-0242","article-title":"Nab-paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer","volume":"2","author":"Frese","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0140","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1093\/carcin\/bgt227","article-title":"Comparative benefits of nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer","volume":"34","author":"Awasthi","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jconrel.2025.02.075_bb0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejca.2021.03.040","article-title":"Gemcitabine\/nab-paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: a propensity score analysis","volume":"151","author":"Riedl","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jconrel.2025.02.075_bb0150","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/0194599812442037","article-title":"Comparative analysis of tumor-infiltrating lymphocytes in a syngeneic mouse model of oral cancer","volume":"147","author":"Judd","year":"2012","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0155","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/jnci\/86.17.1303","article-title":"Altered angiogenesis underlying age-dependent changes in tumor growth","volume":"86","author":"Pili","year":"1994","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0160","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/jnci\/82.1.44","article-title":"Effect of host age on tumor-associated angiogenesis in mice","volume":"82","author":"Kreisle","year":"1990","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0165","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnci\/72.1.161","article-title":"B16 murine melanoma and aging: slower growth and longer survival in old mice","volume":"72","author":"Ershler","year":"1984","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0170","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122961","article-title":"Age-related tumor growth in mice is related to integrin alpha 4 in CD8+ T cells","volume":"3","author":"Oh","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jconrel.2025.02.075_bb0175","doi-asserted-by":"crossref","first-page":"eaaz6606","DOI":"10.1126\/scitranslmed.aaz6606","article-title":"Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy","volume":"12","author":"Lu","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0180","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41565-021-00962-9","article-title":"Amplifying STING activation by cyclic dinucleotide-manganese particles for local and systemic cancer metalloimmunotherapy","volume":"16","author":"Sun","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/cells10010130","article-title":"Calreticulin-multifunctional chaperone in immunogenic cell death: potential significance as a prognostic biomarker in ovarian Cancer patients","volume":"10","author":"Kielbik","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2025.02.075_bb0190","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/s41551-020-0597-7","article-title":"Tumour sensitization via the extended intratumoural release of a STING agonist and camptothecin from a self-assembled hydrogel","volume":"4","author":"Wang","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0195","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0200","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s41048-018-0080-0","article-title":"Detection of cancer cells based on glycolytic-regulated surface electrical charges","volume":"5","author":"Le","year":"2019","journal-title":"Biophys. Rep."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0205","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1007\/s00018-017-2604-z","article-title":"Tumor cell membrane-targeting cationic antimicrobial peptides: novel insights into mechanisms of action and therapeutic prospects","volume":"74","author":"Baxter","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0210","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11010-005-3557-3","article-title":"Changes in electric charge and phospholipids composition in human colorectal cancer cells","volume":"276","author":"Dobrzy\u0144ska","year":"2005","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0215","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1039\/D2TB02059A","article-title":"Mechanistic insights and importance of hydrophobicity in cationic polymers for cancer therapy","volume":"11","author":"Kumar","year":"2023","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2025.02.075_bb0220","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4142\/jvs.2003.4.3.229","article-title":"Altered maturation of dendritic cells by taxol, an anticancer drug","volume":"4","author":"Joo","year":"2003","journal-title":"J. Vet. Sci."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0225","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1021\/acsnano.3c11445","article-title":"Systemic delivery of paclitaxel by find-me nanoparticles activates antitumor immunity and eliminates tumors","volume":"18","author":"Kwon","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.02.075_bb0230","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2172-11-14","article-title":"Differential effects of paclitaxel on dendritic cell function","volume":"11","author":"John","year":"2010","journal-title":"BMC Immunol."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0235","doi-asserted-by":"crossref","first-page":"6936","DOI":"10.7150\/thno.58173","article-title":"A spontaneous multifunctional hydrogel vaccine amplifies the innate immune response to launch a powerful antitumor adaptive immune response","volume":"11","author":"Liang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2025.02.075_bb0240","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.molcel.2019.09.030","article-title":"Mechanisms controlling PD-L1 expression in Cancer","volume":"76","author":"Cha","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jconrel.2025.02.075_bb0245","doi-asserted-by":"crossref","first-page":"29794","DOI":"10.18632\/oncotarget.7631","article-title":"The effect of chemotherapy on programmed cell death 1\/programmed cell death 1 ligand axis: some chemotherapeutical drugs may finally work through immune response","volume":"7","author":"Luo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2025.02.075_bb0250","doi-asserted-by":"crossref","first-page":"14628","DOI":"10.1002\/anie.202006117","article-title":"Sequential and timely combination of a Cancer Nanovaccine with immune checkpoint blockade effectively inhibits tumor growth and relapse","volume":"59","author":"Kim","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0255","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.1158\/1078-0432.CCR-16-2677","article-title":"Timing of PD-1 blockade is critical to effective combination immunotherapy with anti-OX40","volume":"23","author":"Messenheimer","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.964442","article-title":"The role of PD-1\/PD-L1 and application of immune-checkpoint inhibitors in human cancers","volume":"13","author":"Tang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0265","doi-asserted-by":"crossref","first-page":"8437","DOI":"10.2147\/OTT.S221340","article-title":"The role of PD-1\/PD-L1 Axis in Treg development and function: implications for Cancer immunotherapy","volume":"12","author":"Cai","year":"2019","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.jconrel.2025.02.075_bb0270","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.1158\/0008-5472.CAN-19-0053","article-title":"Melanoma extracellular vesicles generate immunosuppressive myeloid cells by upregulating PD-L1 via TLR4 signaling","volume":"79","author":"Fleming","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.02.075_bb0275","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3390\/cancers11091400","article-title":"Blockade of PD-L1 enhances Cancer immunotherapy by regulating dendritic cell maturation and macrophage polarization","volume":"11","author":"Sun","year":"2019","journal-title":"Cancers"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925001889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925001889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T01:56:58Z","timestamp":1769219818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925001889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":55,"alternative-id":["S0168365925001889"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.02.075","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Timely administration of drug combination improves chemoimmunotherapy of an immune-cold tumor","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.02.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113579"}}